FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Top News

Cancer trials halted amid investigations

Although modeling and simulation are likely to become fixtures in drug development, they do come with risks. Just ask Duke University. Enrollment has been suspended in three cancer treatment trials and investigators are now reviewing the data amassed from a project to test whether gene expression can help predict tumor response to drugs. Article

NCI plans clinical trial system reforms

Change is afoot at the National Cancer Institute, and clinical trials may never be the same again. NCI is becoming more data focused in drug development, according to new leadership, and is taking the clinical trial bull by the horns in wrangling onerous administrative and tech tasks in cooperative trials. Article